HIV associated nephropathy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 2: | Line 2: | ||
'''For patient information, click [[AIDS (patient information)|here]]''' | '''For patient information, click [[AIDS (patient information)|here]]''' | ||
{{HIV associated nephropathy}} | {{HIV associated nephropathy}} | ||
{{CMG}} | {{CMG}}{{APM}};{{AE}}{{KW}} | ||
==[[HIV associated nephropathy overview|Overview]]== | ==[[HIV associated nephropathy overview|Overview]]== | ||
Revision as of 16:31, 13 January 2017
For patient information, click here
HIV associated nephropathy Microchapters |
Differentiating HIV associated nephropathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
HIV associated nephropathy On the Web |
American Roentgen Ray Society Images of HIV associated nephropathy |
Risk calculators and risk factors for HIV associated nephropathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2];Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating HIV associated nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | KUB X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies